Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Study ID
NCT00756509

Study type
Interventional

Study phase
Phase 4

Study status
Active, not recruiting

Trial Acronym

Trial Summary

The purpose of this multicenter, single-arm, exact binomial single-stage, phase II trial is to evaluate the efficacy of Nilotinib in patients with unresectable or metastatic gastrointestinal stromal tumors

More informations

Trial Starting Date

Aug 29,2008

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit